Hrt Financial LP Iveric Bio, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $615,521 - $1.22 Million	65,481 New	65,481 $1.17 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $1.78 Million - $2.46 Million	-146,419 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $2.02 Million - $2.75 Million	146,419 New	146,419 $2.45 Million
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $67,210 - $84,692	-11,812 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $60,004 - $81,384	11,812 New	11,812 $72,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.